Objective To undertake a contemporary review of the impact of exercise based cardiac rehabilitation (ExCR) for patients with atrial fibrillation (AF). Data sources CENTRAL, MEDLINE, Embase, PsycINFO, ...
Since my previous coverage, the stock has gained about 1.75%, underperforming the S&P 500 by about 3%. In this updated article, I am empirically estimating the price target for 2027. Technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results